Special Assistant to the Prime Minister (SAPM) on Industries and Production Haroon Akhtar Khan on Wednesday said that the establishment of a pharmaceutical joint venture between Pakistan and Russia marks a significant milestone in strengthening bilateral relations.
The SAPM chaired a high-level meeting, which was also attended by Denis Nazarov, Representative of the Russian Government, senior officials from the Ministry of Industries and Production, Ministry of National Health Services and the Drug Regulatory Authority of Pakistan (DRAP).
Discussions focused on the import of insulin from Russia, progress on pharmaceutical joint ventures, and the development of protocols for policy board implementation.
During the meeting, it was noted that DRAP had earlier granted registration to Genetics Pharmaceuticals, Lahore, for the import of insulin from Russian company Zavod Medsintez.
Khan noted that Pakistan is a major consumer of insulin, and the regular supply of insulin from Russia could greatly benefit diabetic patients across the country.
He further stated that in line with Prime Minister Shehbaz Sharif’s vision, efforts are underway to initiate local manufacturing of insulin in Pakistan. A joint protocol between local manufacturers and Russian companies is expected to be finalized and presented soon.
Khan directed all stakeholders to develop a comprehensive proposal prior to its presentation in the Federal Cabinet.
Stay Connected with ProPakistani
Get the latest business news, market insights, and economic updates wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
The fact that insulin which is Naturally produced is still not locally produced is criminal.
We need insulin production to help our local youths to produce it.
Achievement is to produce insulin API locally.
دو نمبر بنائنگے۔